Antibodies in sera of patients with late-onset myasthenia gravis recognize the PEVK domain of titin.
Mihovilovic
Mirta
M
Division of Neurology, Duke University Medical Center, Durham, North Carolina 27710, USA. mihov001@mc.duke.edu
Ciafaloni
Emma
E
Butterworth-Robinette
Jennifer
J
Jin
Jian-Ping
JP
Massey
Janice
J
Sanders
Donald B
DB
D000328:Adult; D017668:Age of Onset; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D000906:Antibodies / Q000097:blood*; D001666:Binding Sites, Antibody; D064211:Connectin; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D009124:Muscle Proteins / Q000276:immunology*; D009157:Myasthenia Gravis / Q000097:blood / Q000276:immunology*; D009210:Myofibrils / Q000378:metabolism; D010455:Peptides / Q000276:immunology; D011494:Protein Kinases / Q000276:immunology*; D017434:Protein Structure, Tertiary / Q000502:physiology*; D051381:Rats; D013950:Thymus Gland / Q000473:pathology
D000906:Antibodies; D064211:Connectin; D009124:Muscle Proteins; D010455:Peptides; C577285:TTN protein, human; D011494:Protein Kinases